Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Driving skills in unmedicated first- and recurrent-episode schizophrenic patients.

Segmiller FM, Buschert V, Laux G, Nedopil N, Palm U, Furjanic K, Zwanzger P, Brunnauer A.

Eur Arch Psychiatry Clin Neurosci. 2017 Feb;267(1):83-88. doi: 10.1007/s00406-015-0647-4.

PMID:
26499939
2.

Mobility behaviour and driving status of patients with mental disorders - an exploratory study.

Brunnauer A, Buschert V, Segmiller F, Zwick S, Bufler J, Schmauss M, Messer T, Möller HJ, Frommberger U, Bartl H, Steinberg R, Laux G.

Int J Psychiatry Clin Pract. 2016;20(1):40-6. doi: 10.3109/13651501.2015.1089293.

PMID:
26442635
3.

[Neuropsychological treatment of cognitive deficits in substance abuse disorders, affective disorders, anxiety disorders and obsessive-compulsive disorders - current status and perspectives].

Buschert VC, Zwanzger P, Brunnauer A.

Fortschr Neurol Psychiatr. 2015 May;83(5):259-68. doi: 10.1055/s-0034-1399413. Review. German.

PMID:
26018393
4.

Driving performance and psychomotor function in depressed patients treated with agomelatine or venlafaxine.

Brunnauer A, Buschert V, Fric M, Distler G, Sander K, Segmiller F, Zwanzger P, Laux G.

Pharmacopsychiatry. 2015 Mar;48(2):65-71. doi: 10.1055/s-0034-1398509.

PMID:
25642916
5.

[Dementia and driving].

Brunnauer A, Buschert V, Laux G.

Nervenarzt. 2014 Jul;85(7):811-5. doi: 10.1007/s00115-013-3992-4. German.

PMID:
24973013
6.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

7.

Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment.

Buschert VC, Giegling I, Teipel SJ, Jolk S, Hampel H, Rujescu D, Buerger K.

J Clin Psychiatry. 2012 Dec;73(12):e1492-8. doi: 10.4088/JCP.11m07270.

PMID:
23290333
8.

Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease.

Förster S, Buschert VC, Teipel SJ, Friese U, Buchholz HG, Drzezga A, Hampel H, Bartenstein P, Buerger K.

J Alzheimers Dis. 2011;26 Suppl 3:337-48. doi: 10.3233/JAD-2011-0025.

PMID:
21971473
9.

Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.

Förster S, Buschert VC, Buchholz HG, Teipel SJ, Friese U, Zach C, la Fougere C, Rominger A, Drzezga A, Hampel H, Bartenstein P, Buerger K.

J Alzheimers Dis. 2011;25(4):695-706. doi: 10.3233/JAD-2011-100996.

PMID:
21498904
10.

Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.

Buschert VC, Friese U, Teipel SJ, Schneider P, Merensky W, Rujescu D, Möller HJ, Hampel H, Buerger K.

J Alzheimers Dis. 2011;25(4):679-94. doi: 10.3233/JAD-2011-100999.

PMID:
21483095
11.

Cognitive intervention in Alzheimer disease.

Buschert V, Bokde AL, Hampel H.

Nat Rev Neurol. 2010 Sep;6(9):508-17. doi: 10.1038/nrneurol.2010.113. Review.

PMID:
20717104
12.

[Current status of cognition-based interventions in Alzheimer's disease].

Buschert VC, Teipel SJ, Hampel H, Bürger K.

Nervenarzt. 2009 Mar;80(3):273-87. doi: 10.1007/s00115-008-2647-3. Review. German.

PMID:
19229510

Supplemental Content

Loading ...
Support Center